Search

Author/Creator Decker, T

1. 282TiPReal-world effectiveness of ribociclib + aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study. (23rd October 2018)

Authors:
Fasching, P A; Decker, T; Guderian, G; Heim, J; Jackisch, C; Lueck, H-J; Lüftner, D; Marmé, F; Reimer, T; Woeckel, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 295PExploratory biomarker analysis in patients treated with vinorelbine plus everolimus or vinorelbine monotherapy as second-line treatment for HER2-negative advanced breast cancer: Final results from the randomized phase II trial VicTORia. (23rd October 2018)

Authors:
Decker, T; Mündlein, A; Marschner, N; Welt, A; Riedt, T; Hagen, V; Rauh, J; Klein, D; Potthoff, K; Jähnig, P; Schröder, H; Hegewisch-Becker, S; Lerchenmüller, C
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 364TiPAnti-hormonal maintenance treatment with or without the CDK4/6 inhibitor ribociclib after first line chemotherapy in hormone receptor positive/HER2 negative metastatic breast cancer: A phase II trial (AMICA) GBG 97. (23rd October 2018)

Authors:
Decker, T; Denkert, C; Lübbe, K; Müller, V; Mundhenke, C; Furlanetto, J; Schmidt, M; Thill, M; Tierbach, V; Seither, F; Loibl, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 564PTRICC-C: Nintedanib vs. placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: Final results from the randomized phase II trial of the AIO. (23rd October 2018)

Authors:
Ettrich, T J; Berger, A W; Decker, T; Hofheinz, R D; Heinemann, V; Hoffmann, T; Hebart, H F; Herrmann, T; Hannig, C-V; Büchner-Steudel, P; Bartholomäus, H; Güthle, M; Perkhofer, L; Seufferlein, T
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial. (14th November 2019)

Authors:
Stintzing, S; Wirapati, P; Lenz, H -J; Neureiter, D; Fischer von Weikersthal, L; Decker, T; Kiani, A; Kaiser, F; Al-Batran, S; Heintges, T; Lerchenmüller, C; Kahl, C; Seipelt, G; Kullmann, F; Moehler, M; Scheithauer, W; Held, S; Modest, D P; Jung, A; Kirchner, T
Journal:
Annals of oncology
Issue:
Volume 30:Number 11(2019)
Page Start:
1796
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. Issue 7 (25th June 2004)

Authors:
Cserni, G; Amendoeira, I; Apostolikas, N; Bellocq, J P; Bianchi, S; Boecker, W; Borisch, B; Connolly, C E; Decker, T; Dervan, P; Drijkoningen, M; Ellis, I O; Elston, C W; Eusebi, V; Faverly, D; Heikkila, P; Holland, R; Kerner, H; Kulka, J; Jacquemier, J
Journal:
Journal of clinical pathology
Issue:
Volume 57:Issue 7(2004)
Page Start:
695
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. PD-020Age and RAS status to select patients with metastatic colorectal cancer (mCRC) for initial sequential versus combination therapy including fluoropyrimidines (FP), irinotecan (Iri) and bevacizumab (Bev): XELAVIRI- study. (20th June 2018)

Authors:
Modest, D; von Weikersthal, L Fischer; Decker, T; Vehling-Kaiser, U; Uhlig, J; Schenk, M; Freiberg-Richter, J; Peuser, B; Denzlinger, C; Reddemann, C Peveling genannt; Graeven, U; Schuch, G; Schwaner, I; Stahler, A; Jung, A; Kirchner, T; Held, S; Stintzing, S; Giessen-Jung, C; Heinemann, V
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗